CVS Caremark Corp (NYSE:CVS)

CAPS Rating: 4 out of 5

The Company's current operations are grouped into two businesses: Retail Pharmacy and Pharmacy Benefit Management.

Recs

0
Player Avatar brenoboyle (71.09) Submitted: 1/28/2013 11:31:49 PM : Outperform Start Price: $51.07 CVS Score: +4.54

Attractive valuation, buybacks, increased prescription drug coverage, patent cliff increases generics for which CVS has better margins and aging population.

Featured Broker Partners


Advertisement